IP0950- Controlling Perioperative Nausea and Vomiting New Solutions for an Ongoing Problem - Perioperative nausea and vomiting (including postoperative and postdischarge nausea and vomiting [PONV/PDNV]) is an ongoing problem among people undergoing general anesthesia. Depending on the number of risk factors, the incidence of nausea and vomiting in surgical patients can exceed 80%. This monograph is intended to provide current information on PONV and PDNV and their prophylaxis, and to explore the practical implications of recent findings on antiemetic practices in order to enable practitioners to make more informed decisions regarding antiemetic use-both at present and in the future.

SR0953 - Emerging Parenteral Therapies for Multimodal Postoperative Analgesia - Combining analgesics with different mechanisms of action aids the patient in the perioperative setting by targeting more than one pain pathway; this provides additional analgesia and perhaps synergistic pain-relieving effects. A multimodal approach to postoperative pain would provide effective analgesia, reduce opioid-related side effects, and improve clinical outcomes, such as length of hospital stay, morbidity, and mortality. However, the optimal combination of analgesics, dosages, and timing of administration to achieve these outcomes are not known. This monograph outlines the current parenteral treatment options and strategies available for the management of postoperative pain.

SR0960 - Clinical Urine Drug Testing During Opioid Therapy: A Case-Based Approach to Patient Monitoring - According to the recent recommendations from the American Pain Society and American Academy of Pain Medicine, implementing a risk management strategy with opioid therapy will allow the physician to take the patient's history and physical examination into account when administering opioids and while frequently monitoring outcomes using strategies such as urine drug testing (UDT). Given the complexities associated with drug screening, physicians need to have an understanding of how to interpret test results. This activity provides pain-treating physicians with up-to-date information and practical case examples to illustrate the implementation and utility of UDT and monitoring in patients with chronic noncancer pain (CNCP) who are receiving long-term opioid therapy.